News & Insights

From research breakthroughs and company milestones to opportunities to develop your career as we shape the future of radionuclide therapy.

Oct 8, 2025

Read our press release detailing the conclusion of our recent funding round.

Oct 8, 2025

Read our press release detailing the conclusion of our recent funding round.

Oct 8, 2025

Read our press release detailing the conclusion of our recent funding round.

Sep 22, 2025

Nuclide Therapeutics secures £5 million investment to spearhead first-in-human clinical trials.

Sep 22, 2025

Nuclide Therapeutics secures £5 million investment to spearhead first-in-human clinical trials.

Sep 22, 2025

Nuclide Therapeutics secures £5 million investment to spearhead first-in-human clinical trials.

Oct 8, 2025

Read our press release detailing the conclusion of our recent funding round.

Sep 22, 2025

Nuclide Therapeutics secures £5 million investment to spearhead first-in-human clinical trials.

Connect with us

Email us and keep updated on our clinical trial and pipeline development on LinkedIn.

Email us

Email us and keep updated on our clinical trial and pipeline development on LinkedIn.

Email us

Email us and keep updated on our clinical trial and pipeline development on LinkedIn.

Email us

Cookie Policy

Cookie Policy

Cookie Policy